...
首页> 外文期刊>Annals of surgical oncology >Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.
【24h】

Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.

机译:乳腺微钙化的定向真空辅助活检中的非典型导管增生:考虑手术切除。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Our goal was to analyze clinicopathologic features of patients with atypical ductal hyperplasia (ADH) diagnosed on directional vacuum-assisted biopsy (DVAB) targeting microcalcifications to identify factors predicting the presence of carcinoma. MATERIALS AND METHODS: We retrospectively evaluated the clinical, mammographic, and histologic features of 140 patients with DVAB-diagnosed ADH who underwent either segmental excision (86.4%) or mammographic follow-up (>/=2 years; 13.6%). Cases with mass lesions or ipsilateral cancer were excluded. RESULTS: In 16 cases, carcinoma was found on excision. All cases without excision showed no new abnormalities on mammographic follow-up. Only the amount of calcifications removed (2) involved (P = .0306), presence of significant cytologic atypia suspicious for intermediate or high-grade carcinoma (P < .0001), and necrosis (P = .0006). Among ADH cases without significant atypia and/or necrosis, the extent of ADH (2 TDLU involved) was not a significant predictor of carcinoma (P = 1.0000). CONCLUSIONS: ADH associated with calcifications in the absence of a mass lesion can be categorized into different risk groups using a multidisciplinary approach with correlation of histologic and mammographic findings. ADH lesions with significant cytologic atypia and/or necrosis are most likely to be associated with carcinoma and should be excised. ADH without these features, regardless of extent of involvement, and with >95% removal of the targeted calcifications, is associated with a minimal risk (<3%) of carcinoma and may undergo mammographic follow-up only.
机译:背景:我们的目标是分析针对定向微钙化的定向真空辅助活检(DVAB)诊断为非典型性导管增生(ADH)的患者的临床病理特征,以鉴定预测存在癌症的因素。材料与方法:我们回顾性评估了140例经DVAB诊断为ADH的,行节段性切除术(86.4%)或乳房X线摄影随访(> / = 2年; 13.6%)的临床,乳房X线照片和组织学特征。排除具有大块病变或同侧癌的病例。结果:16例在切除时发现癌。所有未切除的病例在乳房X光检查中均未发现新异常。只有去除的钙化量( 2)(P = .0306),是否存在可疑为中级或高级别癌的显着细胞学非典型性(P <.0001)和坏死(P = .0006)。在无明显异型性和/或坏死的ADH病例中,ADH的程度( 2 TDLU涉及)不是癌症的重要预测因子(P = 1.0000)。结论:在无大块病变的情况下,与钙化有关的ADH可采用多学科方法,并结合组织学和乳腺X线摄影表现,分为不同的危险组。具有明显细胞学异型性和/或坏死的ADH病变最可能与癌相关,应切除。不考虑这些特征的ADH,无论其受累程度如何,且靶向钙化的去除率> 95%,与癌症的风险极小(<3%)有关,并且可能仅接受乳房X光检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号